Adam Ron spent eight years at Bank of America piecing together research on health insurers and hospital chains, and somewhere along the way, he started counting subscriptions. A dozen vendors, maybe more. One for hospital cost reports, another for insurance regulatory filings, a third for the sprawling price transparency files the government now requires. Each dataset lived in its own silo, each requiring its own login and export routine.
The experience left him convinced there had to be a better way—or at least a more lucrative business model. So Ron left the sell side and co-founded Soria, a New York startup that participated in Y Combinator's spring 2026 cohort. The pitch? Think Bloomberg Terminal, but narrower: built exclusively for healthcare investors, with AI doing the heavy lifting on data aggregation.
Whether Wall Street needs another terminal is debatable. Whether it needs this terminal may come down to execution.
The Fragmentation Problem
Healthcare remains one of the last corners of finance where research teams still cobble together data from boutique vendors. An analyst covering hospital systems might subscribe to American Hospital Directory for facility metrics, Milliman for actuarial datasets, and Mark Farrah Associates for insurance enrollment figures. Tack on FactSet for general financials and you're easily clearing six figures in annual vendor costs.
Soria's answer is consolidation. The platform monitors over 300 data sources—public datasets, commercial feeds, regulatory filings—and normalizes everything into a single searchable interface. According to a case study published by DBOS, a database orchestration platform Soria uses under the hood, the company ingests hospital price transparency files, insurance statutory filings, and enrollment data, then stores it all in Google BigQuery for querying.
Ron claims the platform can replace upwards of $200,000 in vendor spend for a typical healthcare services investment team. That's the hook for buy-side clients: fewer invoices, one login, faster research cycles.
The technical architecture emphasizes auditability—full data lineage so analysts can trace any figure back to its source document. That matters in a world where regulators and compliance teams scrutinize every footnote.
The Sell-Side Escape
Ron's background informs the product in obvious ways. He covered health insurance, hospitals, and value-based care during his years at BofA, and Soria's feature set mirrors the workflows he knows: tracking NAIC filings, monitoring hospital pricing shifts, modeling enrollment changes quarter by quarter.
His co-founder, Cameron Spiller, brings the engineering chops. Spiller was a founding engineer at Petal and Pinwheel, both fintech plays, and earlier worked at TripleLift in ad tech. It's a classic pairing for a vertical SaaS company—domain expert meets technical co-founder—though whether three people (their team size as of the YC listing this spring) can pull off the data-wrangling Soria promises is an open question.
Funding so far includes Y Combinator and, per the company, backing from the founders of Gerson Lehrman Group, the expert network firm. Soria has also claimed recognition as BattleFin's "#1 New Data Vendor," though no independent verification of that accolade appears in BattleFin's publicly available materials.
Workflow Over Widgets
Beyond aggregation, Soria leans into workflow automation. The platform sends alerts when key data points shift—a major insurer files updated enrollment figures, say, or a hospital system revises its negotiated rates. Users can search across all ingested sources, ask questions in natural language through an AI chat layer, and build dashboards that, in Soria's framing, feel as familiar as Excel.
Speaking of which: the Excel add-in might be the smartest feature. Many analysts still live in spreadsheets, and forcing them onto a new platform wholesale is a tough sell. Soria instead meets them where they work. The warehouse sync follows similar logic—teams running their own data stacks can pull Soria's normalized datasets directly without ever opening the terminal.
There's also an email research feed that pushes updates without requiring a login. These touches suggest Ron and Spiller understand that adoption isn't about flashy demos; it's about reducing friction.
A Messy Opportunity
The timing isn't accidental. Federal price transparency mandates, enforced starting in 2021 for hospitals and 2022 for health plans, have flooded the market with machine-readable files showing negotiated rates and cash prices. In theory, this is a goldmine for researchers. In practice, compliance is patchy, file formats are inconsistent, and the datasets are enormous. A 2025 GAO report flagged ongoing issues with completeness and usability, while researchers from KFF and elsewhere have documented just how hard it is to work with this stuff.
That chaos creates openings for companies willing to wrangle the mess. Soria isn't alone—Turquoise Health and Lumirate also aggregate transparency data. But Soria's angle is targeting buy-side analysts rather than providers or payers. The company claims it already works with teams managing over $1 trillion in assets, though it hasn't named clients publicly or provided independent verification of that figure.
Meanwhile, Bloomberg has been layering AI features into its flagship terminal: natural language search, conversational interfaces, summarization tools. Soria's bet is that depth beats breadth—that going narrow in healthcare, where specialized sources matter more than general market feeds, can carve out defensible territory.
What's Under the Hood
Soria ditched traditional task queues in favor of DBOS, which handles orchestration at the database level. According to the DBOS case study, this shift enabled durable, parallel workflows for processing hundreds of sources in real time. The architecture includes lineage tracking for every data point, critical for research that needs to be auditable.
BigQuery serves as the storage layer, which aligns with the broader trend of financial firms modernizing on cloud-native infrastructure. It's not revolutionary, exactly, but it's table stakes for a product positioning itself as next-generation.
Early Days
Soria exhibited as a silver sponsor at BattleFin's Discovery Day in New York this May, part of the alternative data circuit where vendors pitch buy-side researchers. Combined with YC demo day and the public launch, it's a visibility play aimed squarely at institutional investors.
The company is still tiny—three people as of late spring—and was founded in 2025. The consolidation thesis is straightforward: replace five or six niche vendors with one terminal, capture recurring revenue from asset managers and hedge funds, scale from there.
Whether it works hinges on the unglamorous stuff. Data quality, refresh speed, the accuracy of those AI-generated insights—those matter more than positioning slides. For now, Soria is making a simple wager: that healthcare analysts are tired of the spreadsheet shuffle and ready for something purpose-built.
If Ron's instinct is right, the market might be bigger than he expected. If not, well, there's always another vendor subscription to sell.
